The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.
Lauren Biscaldi
Advertisement
Articles by Lauren Biscaldi
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Infection Control Today
1
Candida auris Is Here to Stay: What Infection Prevention Teams Must Do Now
2
Rising Carbapenemase-Producing Enterobacterales: What Hospitals Need to Know About Emerging Resistance Risks
3
Inclusion Across Different Communities and Care Settings: A Conversation With Colleen Becker, PhD, MSN, RN, CCRN-K
4
Empowering Nurses to Speak Up About Infection Risks: A Conversation With Colleen Becker, PhD, MSN, RN, CCRN-K
5